Cecelia Miller

480 total citations
28 papers, 201 citations indexed

About

Cecelia Miller is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Cecelia Miller has authored 28 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 7 papers in Immunology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Cecelia Miller's work include Chronic Lymphocytic Leukemia Research (18 papers), Immunodeficiency and Autoimmune Disorders (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Cecelia Miller is often cited by papers focused on Chronic Lymphocytic Leukemia Research (18 papers), Immunodeficiency and Autoimmune Disorders (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Cecelia Miller collaborates with scholars based in United States and Italy. Cecelia Miller's co-authors include Amy S. Ruppert, Laura Z. Rassenti, Erin Hertlein, John C. Byrd, Michael R. Grever, Jennifer A. Woyach, Seema A. Bhat, Kerry A. Rogers, Gerard Lozanski and Thomas J. Kipps and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Cecelia Miller

23 papers receiving 197 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cecelia Miller United States 8 101 86 77 63 47 28 201
Reina Improgo United States 4 100 1.0× 107 1.2× 71 0.9× 91 1.4× 51 1.1× 7 231
Veronika Navrkalová Czechia 8 85 0.8× 121 1.4× 38 0.5× 97 1.5× 61 1.3× 18 217
Josef Karban Czechia 8 133 1.3× 140 1.6× 90 1.2× 102 1.6× 113 2.4× 31 300
Natalya Nazaryan United States 5 186 1.8× 134 1.6× 133 1.7× 54 0.9× 111 2.4× 5 319
David Martin‐García Spain 5 90 0.9× 60 0.7× 21 0.3× 82 1.3× 38 0.8× 5 187
Pauline Robbe United Kingdom 5 34 0.3× 91 1.1× 32 0.4× 88 1.4× 42 0.9× 14 137
Doreen te Raa Netherlands 5 128 1.3× 58 0.7× 119 1.5× 37 0.6× 26 0.6× 10 191
Annalisa D’Avola United Kingdom 8 65 0.6× 91 1.1× 23 0.3× 67 1.1× 69 1.5× 13 159
Moez Dawood United States 6 64 0.6× 58 0.7× 31 0.4× 88 1.4× 56 1.2× 11 185
Agata Majchrzak Poland 7 81 0.8× 64 0.7× 18 0.2× 66 1.0× 41 0.9× 22 186

Countries citing papers authored by Cecelia Miller

Since Specialization
Citations

This map shows the geographic impact of Cecelia Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecelia Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecelia Miller more than expected).

Fields of papers citing papers by Cecelia Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecelia Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecelia Miller. The network helps show where Cecelia Miller may publish in the future.

Co-authorship network of co-authors of Cecelia Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Cecelia Miller. A scholar is included among the top collaborators of Cecelia Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecelia Miller. Cecelia Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kahwati, Leila C., Matthew R. Avenarius, Norah L. Crossnohere, et al.. (2025). Multicancer Detection Tests for Screening. Annals of Internal Medicine. 178(11). 1591–1604. 3 indexed citations
2.
Avenarius, Matthew R., et al.. (2025). 2: Artificial intelligence-assisted conventional chromosome analysis to explore clonal dynamics in chronic lymphocytic leukemia. Genetics in Medicine Open. 3. 101919–101919.
3.
Avenarius, Matthew R., Zachary B. Abrams, Ling Guo, et al.. (2025). Novel Recurrent Cytogenetic Abnormalities Predict Overall Survival in Tetraploid/Near-Tetraploid Myelodysplastic Syndrome and Acute Myeloid Leukemia. Cancers. 17(8). 1277–1277.
4.
Kahwati, Leila C., Matthew R. Avenarius, Norah L. Crossnohere, et al.. (2025). Blood-Based Tests for Multiple Cancer Screening: A Systematic Review. 2 indexed citations
5.
Mansour, Anthony G., Ying Huang, Adam S. Kittai, et al.. (2024). Outcomes of Patients with Chronic Lymphocytic Leukemia Discontinuing Bruton Tyrosine Kinase Inhibitors Due to Adverse Effects. Blood. 144(Supplement 1). 4629–4629.
6.
Julian, Dominic, et al.. (2024). CRISPR-Cas9-Mediated Correction of TSC2 Pathogenic Variants in iPSCs from Patients with Tuberous Sclerosis Complex Type 2. The CRISPR Journal. 8(1). 60–70. 1 indexed citations
7.
Kittai, Adam S., Seema A. Bhat, Michael R. Grever, et al.. (2023). Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization. Blood Advances. 7(23). 7239–7242. 4 indexed citations
8.
Miller, Cecelia, et al.. (2023). Transformed Plasmablastic Lymphoma Presenting With Marked Lymphocytosis and Spontaneous Tumor Lysis Syndrome. Journal of Hematology. 12(1). 49–58. 1 indexed citations
9.
Miller, Cecelia, Fang Jin, Pamela J. Snyder, et al.. (2023). Clinical SMN1 and SMN2 Gene-Specific Sequencing to Enhance the Clinical Sensitivity of Spinal Muscular Atrophy Diagnostic Testing. Human Mutation. 2023. 1–7. 1 indexed citations
10.
Kittai, Adam S., Ying Huang, Kyle A. Beckwith, et al.. (2022). Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib. American Journal of Hematology. 98(1). 56–65. 8 indexed citations
11.
Kittai, Adam S., Cecelia Miller, Ying Huang, et al.. (2021). The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib. Blood. 138(23). 2372–2382. 31 indexed citations
12.
Miller, Cecelia, Ying Huang, Amy S. Ruppert, et al.. (2021). Significance of chromosome 2p gain in ibrutinib-treated chronic lymphocytic leukemia patients. Leukemia. 35(11). 3287–3290.
13.
14.
Miller, Cecelia, Ying Huang, Matthew R. Avenarius, et al.. (2021). Normal FISH CLL Represents a Heterogeneous Subgroup Where Prognosis Can be Refined with IGHV Mutational Status. Blood. 138(Supplement 1). 1563–1563. 1 indexed citations
15.
Avenarius, Matthew R., Cecelia Miller, Michael Arnold, et al.. (2020). Genetic Characterization of Pediatric Sarcomas by Targeted RNA Sequencing. Journal of Molecular Diagnostics. 22(10). 1238–1245. 11 indexed citations
16.
Miller, Cecelia, Kristy Lee, Ruthann Pfau, et al.. (2020). Disease-associated mosaic variation in clinical exome sequencing: a two-year pediatric tertiary care experience. Molecular Case Studies. 6(3). a005231–a005231. 19 indexed citations
17.
Miller, Cecelia & Nyla A. Heerema. (2018). Culture and Harvest of CpG-Stimulated Peripheral Blood or Bone Marrow in Chronic Lymphocytic Leukemia. Methods in molecular biology. 1881. 27–34. 1 indexed citations
18.
Miller, Cecelia, et al.. (2018). 24. Abbott Vysis IntelliFISH Hybridization Buffer evaluation on hematological specimens. Cancer Genetics. 224-225. 59–60.
19.
Miller, Cecelia, Amy S. Ruppert, Timothy L. Chen, et al.. (2017). The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia. Oncotarget. 8(16). 25942–25954. 21 indexed citations
20.
Miller, Cecelia, Deborah M. Stephens, Amy S. Ruppert, et al.. (2015). Jumping translocations, a novel finding in chronic lymphocytic leukaemia. British Journal of Haematology. 170(2). 200–207. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reina Improgo Breakdown of academic impact, for papers by Veronika Navrkalová Breakdown of academic impact, for papers by Josef Karban Breakdown of academic impact, for papers by Natalya Nazaryan Breakdown of academic impact, for papers by David Martin‐García Breakdown of academic impact, for papers by Pauline Robbe Breakdown of academic impact, for papers by Doreen te Raa Breakdown of academic impact, for papers by Annalisa D’Avola Breakdown of academic impact, for papers by Moez Dawood Breakdown of academic impact, for papers by Agata Majchrzak
Rankless by CCL
2026